PUBLISHER: IMARC | PRODUCT CODE: 1660672
PUBLISHER: IMARC | PRODUCT CODE: 1660672
Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2025-2033
The global ventricular assist devices market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.3 Billion by 2033, exhibiting a growth rate (CAGR) of 8.06% during 2025-2033. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.
Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.
A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.
Ventricular Assist Devices Market Trends/Drivers:
Increase in the prevalence of heart failure
The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.
Limited availability of donor hearts
The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.
Rise in technological advancements
Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.
Ventricular Assist Devices Industry Segmentation:
Breakup by Product:
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BiVAD)
- Others
Left ventricular assist device (LVAD) represents the most popular product
Breakup by Flow Type:
- Pulsatile Flow
- Non-Pulsatile or Continuous Flow
Non-pulsatile or continuous flow dominates the market
Breakup by Product Type:
- Implantable Ventricular Assist Devices
- Non-implantable Ventricular Assist Devices
Implantable ventricular assist devices represent the largest product type
Breakup by Application:
- Bridge-to-Transplant (BTT) Therapy
- Destination Therapy
- Bridge to Recovery and Bridge to Candidacy
Bridge-to-transplant (BTT) therapy accounts for the majority of the market share
Breakup by End User:
- Ambulatory Surgery Centers
- Hospital
- Others
Hospital holds the leading position in the market
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
- Abbott Laboratories
- Abiomed Inc.
- Berlin Heart GmbH (Syscore GmbH)
- Bivacor Inc.
- Calon Cardio
- Cardiacassist Inc. (LivaNova PLC)
- CHF Solutions Inc.
- Jarvik Heart Inc.
- MAQUET GmbH (Getinge)
- Medtronic Inc.
- Syncardia Systems LLC (Versa Capital Management LLC)
- TandemLife (LivaNova PLC)
- Terumo Corporation
Key Questions Answered in This Report
- 1.How big is the global ventricular assist devices market?
- 2.What is the expected growth rate of the global ventricular assist devices market during 2025-2033?
- 3.What are the key factors driving the global ventricular assist devices market?
- 4.What has been the impact of COVID-19 on the global ventricular assist devices market?
- 5.What is the breakup of the global ventricular assist devices market based on the product?
- 6.What is the breakup of the global ventricular assist devices market based on the flow type?
- 7.What is the breakup of the global ventricular assist devices market based on the product type?
- 8.What is the breakup of the global ventricular assist devices market based on the application?
- 9.What is the breakup of the global ventricular assist devices market based on the end-user?
- 10.What are the key regions in the global ventricular assist devices market?
- 11.Who are the key players/companies in the global ventricular assist devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ventricular Assist Device Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Left Ventricular Assist Device (LVAD)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Right Ventricular Assist Device (RVAD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Biventricular Assist Device (BiVAD)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Flow Type
- 7.1 Pulsatile Flow
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Non-Pulsatile or Continuous Flow
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Product Type
- 8.1 Implantable Ventricular Assist Devices
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Non-implantable Ventricular Assist Devices
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Application
- 9.1 Bridge-to-Transplant (BTT) Therapy
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Destination Therapy
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Bridge to Recovery and Bridge to Candidacy
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by End-User
- 10.1 Ambulatory Surgery Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Hospitals
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Abbott Laboratories
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Abiomed Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Berlin Heart GmbH (Syscore GmbH)
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.4 Bivacor Inc.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.5 Calon Cardio
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.6 Cardiacassist Inc. (LivaNova PLC)
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 CHF Solutions Inc.
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.8 Jarvik Heart Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.9 MAQUET GmbH (Getinge)
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Medtronic Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 SWOT Analysis
- 16.3.12 TandemLife (LivaNova Plc)
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.13 Terumo Corporation
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.13.3 Financials
- 16.3.13.4 SWOT Analysis
- 16.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
- Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2024
- Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2024
- Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2024
- Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2024
- Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2024
- Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2024
- Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
- Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
- Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
- Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million USD), 2025-2033
- Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
- Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million USD), 2025-2033
- Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 8: Global: Ventricular Assist Device Market Structure
- Table 9: Global: Ventricular Assist Device Market: Key Players
